We analyzed epigenetic-sensitive genes involved in cholesterol bioactivity such as LDLR, SREBF2 and ABCA1 in correlation with CHD features and quantitative imaging parameters derived by CCT. This evidence concerns the gene SREBF2 and coronary artery disorder.